"10.1371_journal.pone.0033672","plos one","2012-04-24T00:00:00Z","Antonieta Medina Lara; Jesse Kigozi; Jovita Amurwon; Lazarus Muchabaiwa; Barbara Nyanzi Wakaholi; Ruben E Mujica Mota; A Sarah Walker; Ronnie Kasirye; Francis Ssali; Andrew Reid; Heiner Grosskurth; Abdel G Babiker; Cissy Kityo; Elly Katabira; Paula Munderi; Peter Mugyenyi; James Hakim; Janet Darbyshire; Diana M Gibb; Charles F Gilks; on behalf of the DART Trial Team","Health Economics Group, Peninsula College of Medicine and Dentistry, Exeter University, Exeter, United Kingdom; Joint Clinical Research Centre, Kampala, Uganda; Medical Research Council/Uganda Virus Research Institute Research Unit on AIDS, Entebbe, Uganda; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe; Medical Research Council Clinical Trials Unit, London, United Kingdom; Infectious Diseases Institute, Kampala, Uganda; Faculty of Medicine, Imperial College London, London, United Kingdom","Conceived and designed the experiments: CFG P. Mugyenyi JH AR JD DMG AGB AML ASW P. Munderi. Performed the experiments: P. Mugyenyi HG EK CK P. Munderi RK FS JH AR DMG CFG AGB ASW AML REMM JK JA LM BNW. Analyzed the data: AML REMM. Wrote the paper: AML CFG ASW DMG JK JA LM REMM BNW RK FS AR HG AGB CK EK P. Munderi P. Mugyenyi JH JD.","GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim and Abbott Laboratories donated drugs for DART. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","04","Antonieta Medina Lara","AML",21,TRUE,2,1,2,17,TRUE,TRUE,TRUE,2,"17;18",TRUE
